The effects of estrogen and hormone replacement therapy on cardiovascular systems.
Mehrnoosh HashemzadehRyan RomoJoseph M ArreguinMohammed Reza MovahedPublished in: Future cardiology (2020)
Postmenopausal women have an increased risk of cardiovascular disease, which is believed to correlate with lower estrogen level. There are conflicting data regarding hormone replacement therapy (HRT) based on the timing of this therapy. After large randomized trials showed no cardiovascular benefit of hormone replacement, estrogen replacement therapy was dramatically reduced even though starting hormone replacement in early postmenopausal period had shown significant benefit. There are hardly any reviews discussing in detail the effect of HRT on cardiovascular system while briefly discussing other effects of this therapy in postmenopausal women. The novelty of this review is the comprehensive discussion of this effect that can help researchers and clinicians to design future research or trials. In this manuscript, the effect of HRT on cardiovascular system in clinical trials and basic science will be reported and potentially erroneous conclusions drawn by various studies will be discussed. Furthermore, various noncardiovascular effect of HRT will be analyzed.
Keyphrases
- replacement therapy
- postmenopausal women
- bone mineral density
- smoking cessation
- cardiovascular disease
- clinical trial
- estrogen receptor
- palliative care
- type diabetes
- randomized controlled trial
- body composition
- machine learning
- coronary artery disease
- systematic review
- study protocol
- cardiovascular risk factors
- cardiovascular events
- phase iii